Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (501-510 of 721) with videos related to

Pageof 73
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2011
The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configurationMichael Souvatzoglou, Gregor Weirich, Sarah Schwarzenboeck, et al.
Theranostics|August 22, 2017
<sup>11</sup>C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different InstitutionsConstantin Lapa, Maria J Garcia-Velloso, Katharina Lückerath, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 7, 2020
<sup>18</sup>F-flutemetamol positron emission tomography in cardiac amyloidosisMaria Papathanasiou, Lukas Kessler, Alexander Carpinteiro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate CancerAndrei Gafita, Loic Djaileb, Isabel Rauscher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2018
Detection Threshold and Reproducibility of <sup>68</sup>Ga-PSMA11 PET/CT in a Mouse Model of Prostate CancerKatharina Lückerath, Andreea D Stuparu, Liu Wei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2018
Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing <sup>18</sup>F-FDG-PET/MRIJulian Kirchner, Johannes Grueneisen, Ole Martin, et al.
European Radiology|April 12, 2023
Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition timesKai Jannusch, Maike E Lindemann, Nils Martin Bruckmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2023
Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [<sup>18</sup>F]FDG-PET/MRIKai Jannusch, Frederic Dietzel, Nils Martin Bruckmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 11, 2025
How Rapidly Does the FAPI PET Signal Reverse Following Therapy? Assessing the FAPI PET Signal in Hypertensive Cardiac Injury and Fibrosis in MiceAtefeh Hosseini, Elias Haj-Yehia, Sebastian Korste, et al.
European Urology|April 9, 2025
Corrigendum to "Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [<sup>177</sup>Lu]Lu-PSMA-617 in the Phase 3 VISION Trial" [Eur. Urol. 86 (2024) 552-562]Andrew J Armstrong, Oliver Sartor, Johann de Bono, et al.
Pageof 73

Showing results (501-510 of 721) with videos related to

Sort By:
Pageof 73
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2011
The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configurationMichael Souvatzoglou, Gregor Weirich, Sarah Schwarzenboeck, et al.
Theranostics|August 22, 2017
<sup>11</sup>C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different InstitutionsConstantin Lapa, Maria J Garcia-Velloso, Katharina Lückerath, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 7, 2020
<sup>18</sup>F-flutemetamol positron emission tomography in cardiac amyloidosisMaria Papathanasiou, Lukas Kessler, Alexander Carpinteiro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate CancerAndrei Gafita, Loic Djaileb, Isabel Rauscher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2018
Detection Threshold and Reproducibility of <sup>68</sup>Ga-PSMA11 PET/CT in a Mouse Model of Prostate CancerKatharina Lückerath, Andreea D Stuparu, Liu Wei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2018
Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing <sup>18</sup>F-FDG-PET/MRIJulian Kirchner, Johannes Grueneisen, Ole Martin, et al.
European Radiology|April 12, 2023
Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition timesKai Jannusch, Maike E Lindemann, Nils Martin Bruckmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2023
Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [<sup>18</sup>F]FDG-PET/MRIKai Jannusch, Frederic Dietzel, Nils Martin Bruckmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 11, 2025
How Rapidly Does the FAPI PET Signal Reverse Following Therapy? Assessing the FAPI PET Signal in Hypertensive Cardiac Injury and Fibrosis in MiceAtefeh Hosseini, Elias Haj-Yehia, Sebastian Korste, et al.
European Urology|April 9, 2025
Corrigendum to "Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [<sup>177</sup>Lu]Lu-PSMA-617 in the Phase 3 VISION Trial" [Eur. Urol. 86 (2024) 552-562]Andrew J Armstrong, Oliver Sartor, Johann de Bono, et al.
Pageof 73